Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | parathyroid hormone 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | transcription factor SMAD2 | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Loa Loa (eye worm) | MH2 domain-containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Schistosoma japonicum | ko:K04588 secretin receptor, putative | Get druggable targets OG5_139196 | All targets in OG5_139196 |
Brugia malayi | MH2 domain containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0047 | 0.2404 | 0.2262 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.2404 | 0.2804 |
Plasmodium falciparum | glutathione reductase | 0.0039 | 0.1761 | 1 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0039 | 0.1761 | 0.1607 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0039 | 0.1761 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.3412 | 0.3412 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0099 | 0.6479 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0047 | 0.2404 | 0.2404 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.2404 | 0.2804 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.2404 | 0.2804 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0039 | 0.1761 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.2404 | 0.2812 |
Brugia malayi | glutathione reductase | 0.0039 | 0.1761 | 0.1761 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0026 | 0.0719 | 0.087 |
Mycobacterium tuberculosis | Probable reductase | 0.0089 | 0.5697 | 0.8342 |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.495 | 0.4855 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.1918 | 0.2233 |
Trypanosoma brucei | trypanothione reductase | 0.0039 | 0.1761 | 1 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0089 | 0.5697 | 0.8342 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.012 | 0.8078 | 0.9472 |
Brugia malayi | Melibiase family protein | 0.008 | 0.495 | 0.495 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.1918 | 0.1918 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0019 | 0.0184 | 0.0184 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.008 | 0.495 | 0.5796 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.2404 | 0.2812 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 1 | 1 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0089 | 0.5697 | 0.8342 |
Echinococcus granulosus | Alpha N acetylgalactosaminidase | 0.012 | 0.8078 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0719 | 0.0545 |
Plasmodium falciparum | thioredoxin reductase | 0.0039 | 0.1761 | 1 |
Echinococcus multilocularis | Glycoside hydrolase, family 27 | 0.012 | 0.8078 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.3412 | 0.3412 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.004 | 0.1802 | 0.205 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.2404 | 0.2812 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0099 | 0.6479 | 1 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.008 | 0.495 | 0.5796 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.012 | 0.8078 | 0.9472 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0089 | 0.5697 | 0.8342 |
Leishmania major | trypanothione reductase | 0.0039 | 0.1761 | 1 |
Toxoplasma gondii | thioredoxin reductase | 0.0039 | 0.1761 | 0.2163 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0019 | 0.0184 | 0.0184 |
Echinococcus multilocularis | Alpha N acetylgalactosaminidase | 0.012 | 0.8078 | 1 |
Plasmodium vivax | glutathione reductase, putative | 0.0039 | 0.1761 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0184 | 0.0195 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.3412 | 0.3289 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0099 | 0.6479 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.2404 | 0.2812 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.3412 | 0.3289 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.1918 | 0.1767 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0184 | 0.0195 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.012 | 0.8078 | 0.9472 |
Brugia malayi | Thioredoxin reductase | 0.0039 | 0.1761 | 0.1761 |
Loa Loa (eye worm) | glutathione reductase | 0.0039 | 0.1761 | 0.1607 |
Brugia malayi | hypothetical protein | 0.0026 | 0.0719 | 0.0719 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.004 | 0.1802 | 0.205 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0099 | 0.6479 | 1 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0089 | 0.5697 | 0.8342 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 1 | 1 |
Toxoplasma gondii | melibiase subfamily protein | 0.012 | 0.8078 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0184 | 0.0195 |
Trichomonas vaginalis | alpha-galactosidase/alpha-N-acetylgalactosaminidase, putative | 0.008 | 0.495 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0184 | 0.0195 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.012 | 0.8078 | 0.9472 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0089 | 0.5697 | 0.8342 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 2.0787 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 6.3096 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.